Investor Relations

OVERVIEW

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development over time of multiple applications of the company’s lead compound FSD201, ultra-micronized PEA.

COMPANY INFORMATION

Legal Counsel
Blake, Cassels & Graydon LLP

Auditor
MNP LLP

Fiscal Year End
December 31

Jurisdiction
Ontario, Canada

Transfer Agent
Computershare Trust Corporation

STOCK QUOTE

RECENT EVENTS

RECENT NEWS